Text Versions

Text as it was Introduced in Senate

January 23, 2025

View

Terms of Service

This is not an official government website.

United StatesSenate Bill 229S 229

DTC Act of 2025

Health

senate

House Votes

Vote Data Not Available

Senate Votes

Pending Committee

January 23, 2025 (1 year ago)

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

Presidential Signature

Signature Data Not Available

What do you think?

Sponsors (10)

AI Summary

Text Versions

Text as it was Introduced in Senate

January 23, 2025

View

Amendments

No Amendments

Amendments

No Amendments

Sponsors (10)

What do you think?

House Votes

Vote Data Not Available

Senate Votes

Pending Committee

January 23, 2025 (1 year ago)

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

Presidential Signature

Signature Data Not Available

AI Summary

United StatesSenate Bill 229S 229

DTC Act of 2025

Health

senate

Requires most direct-to-consumer prescription drug and biologic advertisements to display a clear price measure so patients and programs can see how much drugs cost. By July 1, 2026, ads must show the wholesale acquisition cost (WAC) for a 30‑day supply (or a typical course of treatment), with a limited exemption for products with a WAC under $35; the Secretary must issue implementing rules and may impose civil penalties for violations.

house

president

Introduced January 23, 2025 by Richard Joseph Durbin · Last progress 1 year ago

OhiorepresentativeDavid J. Taylor

HR-3789Bill

Health

DTC Act of 2025

house

senate

president

8 cosponsorsUpdated 1 hour agoLast progress June 5, 2025